Breakthrough Designation for Biomimetic OsStic Bone Void Filler

Biomimetic OsStic Bone Void Filler

Biomimetic Innovations' OsStic was granted Breakthrough Device designation by FDA.

The proposed indication statement for this novel new technology is, “OsStic Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation or void filling of peri-articular fractures or defects to...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0